CARL DOMINO INC - STEMLINE THERAPEUTICS INC ownership

STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 71 filers reported holding STEMLINE THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.

Quarter-by-quarter ownership
CARL DOMINO INC ownership history of STEMLINE THERAPEUTICS INC
ValueSharesWeighting
Q3 2017$289,000
+20.9%
26,0000.0%0.35%
+27.0%
Q2 2017$239,000
+7.7%
26,0000.0%0.28%
+14.4%
Q1 2017$222,000
-20.1%
26,0000.0%0.24%
-18.2%
Q4 2016$278,000
+4.1%
26,0000.0%0.30%
+17.4%
Q3 2016$267,000
+50.0%
26,000
-1.2%
0.25%
+51.5%
Q2 2016$178,000
+63.3%
26,305
+12.9%
0.17%
+67.0%
Q1 2016$109,000
-6.0%
23,305
+27.3%
0.10%
+9.9%
Q4 2015$116,000
-41.4%
18,305
+9.0%
0.09%
-32.6%
Q2 2015$198,000
+7.0%
16,796
+31.3%
0.14%
-2.2%
Q1 2015$185,000
-26.6%
12,796
-13.5%
0.14%
+1.5%
Q4 2014$252,000
-9.0%
14,796
-33.3%
0.14%
-8.7%
Q3 2014$277,000
+30.0%
22,196
+53.1%
0.15%
+40.6%
Q2 2014$213,000
-10.1%
14,500
+19.8%
0.11%
-17.8%
Q4 2013$237,00012,1000.13%
Other shareholders
STEMLINE THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Eventide Asset Management 579,800$7,224,0001.01%
VHCP Management, LLC 71,000$884,0000.40%
Healthcare Value Capital, LLC 16,464$205,0000.20%
CARL DOMINO INC 22,196$277,0000.15%
TFS CAPITAL LLC 120,112$1,497,0000.13%
Private Capital Advisors, Inc. 31,064$387,0000.12%
Artal Group S.A. 170,000$2,118,0000.08%
TimesSquare Capital Management, LLC 801,225$9,983,0000.06%
Baker Brothers Advisors 338,671$4,220,0000.05%
STONERIDGE INVESTMENT PARTNERS LLC 19,399$242,0000.04%
View complete list of STEMLINE THERAPEUTICS INC shareholders